Stock 600763 TOPCHOICE MEDICAL CO., INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Topchoice Medical Co., Inc.

Equities

600763

CNE000000MZ8

Healthcare Facilities & Services

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-05-23 pm EDT 		5-day change 1st Jan Change
60.67 CNY -4.91% Intraday chart for Topchoice Medical Co., Inc. -5.51% -20.64%
Apr. 25 Topchoice Medical Co., Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 25 Topchoice Medical Co., Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 32,875 88,663 63,807 49,055 24,513 19,404 - -
Enterprise Value (EV) 1 32,773 88,275 63,240 48,594 24,327 19,025 18,455 17,719
P/E ratio 71.2 x 180 x 90.9 x 89.5 x 49 x 33.6 x 26.7 x 24.5 x
Yield - - - - 0.57% 0.27% 0.3% 0.28%
Capitalization / Revenue 17.4 x 42.5 x 22.9 x 18 x 8.61 x 6.1 x 5.18 x 4.62 x
EV / Revenue 17.3 x 42.3 x 22.7 x 17.9 x 8.55 x 5.98 x 4.92 x 4.22 x
EV / EBITDA 45.5 x 114 x 58.5 x 56.4 x 28.5 x 18.5 x 15.6 x 14 x
EV / FCF - - 111 x 195 x 72.7 x 34 x 28 x 19.1 x
FCF Yield - - 0.9% 0.51% 1.38% 2.94% 3.58% 5.24%
Price to Book 18.4 x 41.2 x 22.2 x 14.8 x 6.44 x 4.44 x 3.71 x 3.33 x
Nbr of stocks (in thousands) 320,640 320,640 320,640 320,640 320,640 319,831 - -
Reference price 2 102.5 276.5 199.0 153.0 76.45 60.67 60.67 60.67
Announcement Date 4/23/20 4/9/21 4/27/22 4/27/23 4/25/24 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 1,894 2,088 2,781 2,719 2,847 3,181 3,748 4,197
EBITDA 1 720.2 771.5 1,081 861.6 852.4 1,028 1,181 1,266
EBIT 1 633.8 678.6 974.9 733.9 711.9 804.4 1,005 1,114
Operating Margin 33.46% 32.5% 35.06% 27% 25.01% 25.29% 26.83% 26.54%
Earnings before Tax (EBT) 1 633.4 680.1 974.6 738 708.9 811.8 1,013 1,120
Net income 1 463.1 492.6 702.8 548.3 500.5 578.7 727.9 794.3
Net margin 24.45% 23.59% 25.27% 20.17% 17.58% 18.19% 19.42% 18.92%
EPS 2 1.440 1.540 2.190 1.710 1.560 1.804 2.270 2.477
Free Cash Flow 1 - - 572.1 249.1 334.5 559 660 929
FCF margin - - 20.57% 9.16% 11.75% 17.57% 17.61% 22.13%
FCF Conversion (EBITDA) - - 52.91% 28.92% 39.24% 54.35% 55.86% 73.38%
FCF Conversion (Net income) - - 81.4% 45.44% 66.84% 96.6% 90.67% 116.95%
Dividend per Share 2 - - - - 0.4350 0.1637 0.1848 0.1700
Announcement Date 4/23/20 4/9/21 4/27/22 4/27/23 4/25/24 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 - 663.5 821.2 579.2 674.5 688.1 822.2 661.7 708.4 758.1 904.6 716.3
EBITDA - - - - - - - - - - - -
EBIT 1 - 175.1 282 51.96 225 176.8 282.4 27.71 - 170.6 300.4 81.54
Operating Margin - 26.38% 34.34% 8.97% 33.36% 25.69% 34.35% 4.19% - 22.51% 33.2% 11.38%
Earnings before Tax (EBT) - - - 51.38 224.7 176.2 282.1 - - - - -
Net income 166.5 - - 33.1 169 135.4 207.3 - - - - -
Net margin - - - 5.71% 25.05% 19.68% 25.22% - - - - -
EPS 2 0.5200 0.4000 0.6900 0.1000 0.5300 0.4200 0.6500 -0.0400 0.5400 0.4200 0.7100 0.1100
Dividend per Share - - - - - - - - - - - -
Announcement Date 4/27/22 8/22/22 10/24/22 4/27/23 4/27/23 8/24/23 10/24/23 4/25/24 4/25/24 - - -
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - - -
Net Cash position 1 103 389 568 461 186 379 949 1,685
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 - - 572 249 335 559 660 929
ROE (net income / shareholders' equity) 29.9% 24.4% 27.9% 17.6% 14.1% 13.9% 14.7% 14.5%
ROA (Net income/ Total Assets) 19.3% 17.1% 17.5% 10.8% - 8.97% 9.43% 9.1%
Assets 1 2,396 2,877 4,010 5,055 - 6,454 7,723 8,729
Book Value Per Share 2 5.570 6.710 8.980 10.30 11.90 13.70 16.30 18.20
Cash Flow per Share 2 2.020 2.210 2.930 2.090 2.620 2.850 3.000 3.490
Capex 1 126 166 367 421 505 309 293 317
Capex / Sales 6.64% 7.94% 13.21% 15.48% 17.76% 9.72% 7.83% 7.54%
Announcement Date 4/23/20 4/9/21 4/27/22 4/27/23 4/25/24 - - -
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Topchoice Medical Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
60.67 CNY
Average target price
69.09 CNY
Spread / Average Target
+13.88%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Doctor's Office

1st Jan change Capi.
TOPCHOICE MEDICAL CO., INC. Stock Topchoice Medical Co., Inc.
-20.64% 2.68B
HUAXIA EYE HOSPITAL GROUP CO.,LTD. Stock Huaxia Eye Hospital Group Co.,Ltd.
-25.02% 2.77B
EUROEYES INTERNATIONAL EYE CLINIC LIMITED Stock EuroEyes International Eye Clinic Limited
+0.38% 223M
AIRSCULPT TECHNOLOGIES, INC. Stock AirSculpt Technologies, Inc.
-53.14% 202M
MEDSCI HEALTHCARE HOLDINGS LIMITED Stock MedSci Healthcare Holdings Limited
-42.77% 187M
AESTHETIC CONNECT Stock Aesthetic Connect
-36.31% 109M
Doctor's Office
  1. Stock Market
  2. Equities
  3. 600763 Stock
  4. Financials Topchoice Medical Co., Inc.